Stephen Killer
Associate Director, Country Operations Management at Alexion Pharmaceuticals, Inc. | Australia
Stephen Killer’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
ContactOut Insights • AI Generated
Stephen Killer serves as Associate Director of Country Operations Management at Alexion Pharmaceuticals, where he coordinates regional operational initiatives within the Australian health and wellness market. An alumnus of The University of Sheffield, he supports the company’s broader mission to diversify its therapeutic pipeline and expand AstraZeneca Rare Disease’s geographic presence. His work focuses on streamlining country-level functions to accelerate patient access to novel rare disease treatments.
BEST APPROACH TO REACH Stephen Killer
Initiate contact via personal email, which carries the strongest data confidence scores, by sending a concise proposal that demonstrates how your operational technology reduces regional compliance overhead for rare disease commercial teams.
Associate Director, Country Operations Management at Alexion Pharmaceuticals, Inc. in August 2025 - Present
Study Start Up Associate Director at AstraZeneca in July 2024 - August 2025
Senior Study Associate Director at AstraZeneca in October 2021 - August 2025
Senior Project Manager at AstraZeneca in July 2021 - October 2021
Project Manager at AstraZeneca in January 2021 - July 2021
Director of Project Management at Nucleus Network in May 2020 - October 2020
Clinical Operations Manager at QuintilesIMS in March 2017 - April 2020
Associate Clinical Operations Manager at Quintiles in February 2016 - March 2017
Senior Clinical Research Associate II at Quintiles in June 2014 - January 2016
Senior Clinical Research Associate at Quintiles in October 2011 - December 2012
Clinical Research Associate at Quintiles in March 2010 - October 2011
Clinical Trials Assistant / Trainee CRA at Quintiles in November 2008 - March 2010
CRO Resourcing Consultant at Clinical Professionals in April 2008 - November 2008
The University of Sheffield, 2:1, July 2026
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community. We are driven by a mission to change what it means to live with a rare disease. A leader in rare disease for more than three decades and today continues to build a diversified pipeline across disease areas with significant unmet need, using an array of innovative modalities. As part of AstraZeneca, Alexion is continually expanding its global geographic footprint to serve more rare disease patients around the world. It is headquartered in Boston, US. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally. GL/NP/0116 GL/NP/0095 Community Guidelines: https://bit.ly/39x9gqy
Discover more about Alexion Pharmaceuticals, Inc.
Strategic Corporate Communications and Public Relations Leader | Crisis & Issues Management | Change & Transformation | ESG | Certified Chief of Staff
Founder and Principal at SDB Communications
(February 2024 – Present)
Patient Centric Marketer | AstraZeneca Rare Disease
Associate Director, US Patient Marketing, Neurology, gMG at Alexion Pharmaceuticals, Inc.
(July 2024 – Present)
Strategic leader in Bio Pharma with a passion for patient access to health innovations.
Head of Market Access at Alexion Pharmaceuticals, Inc.
(October 2024 – Present)
Nonclinical Drug Safety and Toxicology/Drug Development/Regulatory Filings/Global and Cross-Functional Teams/Building Confidence in Safety
Senior Director, Nonclinical Toxicology at Alexion Pharmaceuticals, Inc.
(April 2023 – Present)
Consultora de Doenças Raras
Consultora Técnica - COVID-19 - Vaccines & Immune Therapies at AstraZeneca
(February 2022 – Present)
Global Marketing Event Management | Innovation and Continual Process Improvement | Medical Congress Strategy and Engagement | Biotech Virtual & Hybrid Events
Associate Director, Event Strategy and Operations, Congress Lead at Alexion Pharmaceuticals, Inc.
(January 2022 – Present)
What is Stephen Killer email address?
Email Stephen Killer at [email protected] and [email protected]. This email is the most updated Stephen Killer's email found in 2026.
What is Stephen Killer phone number?
Stephen Killer phone number is +61405415898.
How to contact Stephen Killer?
To contact Stephen Killer send an email to [email protected] or [email protected]. If you want to call Stephen Killer try calling on +61405415898. (updated on December 09, 2025)
What company does Stephen Killer work for?
Stephen Killer works for Alexion Pharmaceuticals, Inc..
What is Stephen Killer's role at Alexion Pharmaceuticals, Inc.?
Stephen Killer is Associate Director, Country Operations Management
What industry does Stephen Killer work in?
Stephen Killer works in the Health, Wellness & Fitness industry.
